DellOca M, Quadri R, Bernini G, Menin L, Grasso L, Rondelli D
Int J Mol Sci. 2024; 25(6).
PMID: 38542135
PMC: 10970550.
DOI: 10.3390/ijms25063162.
Huang R, Feng Y, Gao Z, Ahmed A, Zhang W
Int J Mol Sci. 2024; 25(1).
PMID: 38203805
PMC: 10779103.
DOI: 10.3390/ijms25010634.
Le Senechal R, Keruzore M, Quillevere A, Loaec N, Dinh V, Reznichenko O
Nucleic Acids Res. 2023; 51(20):11239-11257.
PMID: 37811881
PMC: 10639069.
DOI: 10.1093/nar/gkad772.
Rota Sperti F, Mitteaux J, Zell J, Pipier A, Valverde I, Monchaud D
RSC Chem Biol. 2023; 4(7):456-465.
PMID: 37415864
PMC: 10320843.
DOI: 10.1039/d3cb00009e.
Moreira D, Lopes-Nunes J, Santos F, Campello M, Oliveira M, Paulo A
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242534
PMC: 10221175.
DOI: 10.3390/ph16050751.
Taq-Polymerase Stop Assay to Determine Target Selectivity of G4 Ligands in Native Promoter Sequences of , , and Oncogenes.
Chashchina G, Tevonyan L, Beniaminov A, Kaluzhny D
Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111301
PMC: 10142109.
DOI: 10.3390/ph16040544.
Can G-quadruplex become a promising target in HBV therapy?.
Teng Y, Zhu M, Chi Y, Li L, Jin Y
Front Immunol. 2023; 13:1091873.
PMID: 36591216
PMC: 9797731.
DOI: 10.3389/fimmu.2022.1091873.
Deciphering RNA G-quadruplex function during the early steps of HIV-1 infection.
Amrane S, Jaubert C, Bedrat A, Rundstadler T, Recordon-Pinson P, Aknin C
Nucleic Acids Res. 2022; 50(21):12328-12343.
PMID: 36453997
PMC: 9757044.
DOI: 10.1093/nar/gkac1030.
Optimization of G-Quadruplex Ligands through a SAR Study Combining Parallel Synthesis and Screening of Cationic Bis(acylhydrazones).
Reznichenko O, Leclercq D, Franco Pinto J, Mouawad L, Gabelica V, Granzhan A
Chemistry. 2022; 29(4):e202202427.
PMID: 36286608
PMC: 10099395.
DOI: 10.1002/chem.202202427.
Click-Chemistry-Based Biomimetic Ligands Efficiently Capture G-Quadruplexes and Help Localize Them at DNA Damage Sites in Human Cells.
Rota Sperti F, Dupouy B, Mitteaux J, Pipier A, Pirrotta M, Cheron N
JACS Au. 2022; 2(7):1588-1595.
PMID: 35911444
PMC: 9327089.
DOI: 10.1021/jacsau.2c00082.
Tetraphenylethene derivative that discriminates parallel G-quadruplexes.
Liu L, Zhang W, Zhong M, Jia M, Jiang F, Zhang Y
RSC Adv. 2022; 12(23):14765-14775.
PMID: 35702216
PMC: 9109478.
DOI: 10.1039/d2ra01433e.
Binding Properties of RNA Quadruplex of SARS-CoV-2 to Berberine Compared to Telomeric DNA Quadruplex.
Oliva R, Mukherjee S, Manisegaran M, Campanile M, Del Vecchio P, Petraccone L
Int J Mol Sci. 2022; 23(10).
PMID: 35628500
PMC: 9145931.
DOI: 10.3390/ijms23105690.
Linear consecutive hexaoxazoles as G4 ligands inducing chair-type anti-parallel topology of a telomeric G-quadruplex.
Sasaki S, Ma Y, Ishizuka T, Bao H, Hirokawa T, Xu Y
RSC Adv. 2022; 10(71):43319-43323.
PMID: 35519695
PMC: 9058415.
DOI: 10.1039/d0ra09413g.
Major Achievements in the Design of Quadruplex-Interactive Small Molecules.
Mendes E, Aljnadi I, Bahls B, Victor B, Paulo A
Pharmaceuticals (Basel). 2022; 15(3).
PMID: 35337098
PMC: 8953082.
DOI: 10.3390/ph15030300.
A complementary chemical probe approach towards customized studies of G-quadruplex DNA structures in live cells.
Prasad B, Doimo M, Andreasson M, LHote V, Chorell E, Wanrooij S
Chem Sci. 2022; 13(8):2347-2354.
PMID: 35310480
PMC: 8864707.
DOI: 10.1039/d1sc05816a.
BrdU immuno-tagged G-quadruplex ligands: a new ligand-guided immunofluorescence approach for tracking G-quadruplexes in cells.
Masson T, Landras Guetta C, Laigre E, Cucchiarini A, Duchambon P, Teulade-Fichou M
Nucleic Acids Res. 2021; 49(22):12644-12660.
PMID: 34875077
PMC: 8682774.
DOI: 10.1093/nar/gkab1166.
Dual targeting of higher-order DNA structures by azacryptands induces DNA junction-mediated DNA damage in cancer cells.
Zell J, Duskova K, Chouh L, Bossaert M, Cheron N, Granzhan A
Nucleic Acids Res. 2021; 49(18):10275-10288.
PMID: 34551430
PMC: 8501980.
DOI: 10.1093/nar/gkab796.
A robust photoluminescence screening assay identifies uracil-DNA glycosylase inhibitors against prostate cancer.
Li G, Henry S, Liu H, Kang T, Nao S, Zhao Y
Chem Sci. 2021; 11(7):1750-1760.
PMID: 34123270
PMC: 8148385.
DOI: 10.1039/c9sc05623h.
Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting.
Miranda A, Santos T, Largy E, Cruz C
Pharmaceuticals (Basel). 2021; 14(2).
PMID: 33557379
PMC: 7916057.
DOI: 10.3390/ph14020121.
Triarylpyridine Compounds and Chloroquine Act in Concert to Trigger Lysosomal Membrane Permeabilization and Cell Death in Cancer Cells.
Beauvarlet J, Nath Das R, Alvarez-Valadez K, Martins I, Muller A, Darbo E
Cancers (Basel). 2020; 12(6).
PMID: 32570977
PMC: 7352983.
DOI: 10.3390/cancers12061621.